Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats
Open Access
- 1 February 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 104 (2) , 575-579
- https://doi.org/10.1016/0016-5085(93)90429-g
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Role of Nitric Oxide in the Vascular Hyporesponsiveness to Methoxamine in Portal Hypertensive RatsHepatology, 1992
- Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive ratsHepatology, 1992
- Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertensionBritish Journal of Pharmacology, 1992
- Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endotheliumBritish Journal of Pharmacology, 1989
- Vasoactive intestinal peptide evokes endothelium-dependent relaxation and cyclic AMP accumulation in rat aortaPeptides, 1988
- EFFECT OF A NEW SOMATOSTATIN ANALOGUE SMS 201-995 (SANDOSTATIN) ON THE RENIN-ALDOSTERONE AXISClinical Endocrinology, 1988
- Effect of a selective octapeptide analogue of somatostatin on renal water excretion in the dogMetabolism, 1985
- SomatostatinNew England Journal of Medicine, 1983
- Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zoneNature, 1981
- INHIBITION OF FRUSEMIDE-INDUCED HYPERRENINÆMIA BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN MANThe Lancet, 1976